Stocksigma LogoStocksigma Logo

CRISIL Issues Monitoring Agency Report for Molbio Diagnostics' IPO Proceeds

CRISIL Ratings released the Monitoring Agency Report for Molbio Diagnostics for the quarter ended 30th Sep'26, reporting zero deviation in the utilization

CRISIL Issues Monitoring Agency Report for Molbio Diagnostics' IPO Proceeds

Molbio Diagnostics Ltd 路 Others (Uncategorized) 路 07 Nov 2026, 1:35 am

CRISIL Issues Monitoring Agency Report for Molbio Diagnostics' IPO Proceeds CRISIL Ratings released the Monitoring Agency Report for Molbio Diagnostics for the quarter ended 30th Sep'26, reporting zero deviation in the utilization of IPO proceeds. Out of the gross proceeds of Rs 2,000.00 million (net proceeds of Rs 1,872.81 million), the company utilized Rs 67.96 million toward plant, machinery, and equipment procurement across Goa and Visakhapatnam units. The remaining unutilized amount of Rs 1,932.04 million is securely deployed across bank fixed deposits (Rs 1,650.00 million), the monitoring account (Rs 154.85 million), and the public issue account.

Original exchange filing (PDF)

More announcements from Molbio Diagnostics Ltd

All Molbio Diagnostics Ltd announcements